A. Hempel

495 total citations
38 papers, 421 citations indexed

About

A. Hempel is a scholar working on Organic Chemistry, Molecular Biology and Inorganic Chemistry. According to data from OpenAlex, A. Hempel has authored 38 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 16 papers in Molecular Biology and 9 papers in Inorganic Chemistry. Recurrent topics in A. Hempel's work include Crystal structures of chemical compounds (9 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers) and Chemical Reaction Mechanisms (5 papers). A. Hempel is often cited by papers focused on Crystal structures of chemical compounds (9 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers) and Chemical Reaction Mechanisms (5 papers). A. Hempel collaborates with scholars based in Canada, United States and Greece. A. Hempel's co-authors include N. Camerman, A. Camerman, D. Mastropaolo, B. G. Lane, Henrianna Pang, D. D. Wood, Mario A. Moscarello, Kwok‐Pui Fung, Tai-Wing Wu and Jun Wu and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

A. Hempel

36 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Hempel Canada 11 187 151 50 44 37 38 421
M. Iqbal India 12 436 2.3× 114 0.8× 37 0.7× 87 2.0× 49 1.3× 17 586
Clarisse Maechling France 7 283 1.5× 54 0.4× 26 0.5× 42 1.0× 22 0.6× 12 440
Manabu Kitazawa Japan 13 299 1.6× 152 1.0× 41 0.8× 35 0.8× 10 0.3× 25 693
Jeffery B. Press United States 18 281 1.5× 748 5.0× 51 1.0× 39 0.9× 31 0.8× 63 1.1k
Larry W. Jaques United States 8 229 1.2× 152 1.0× 28 0.6× 70 1.6× 28 0.8× 14 441
Jon Uranga Germany 11 188 1.0× 101 0.7× 84 1.7× 37 0.8× 11 0.3× 18 406
Boxue Tian Sweden 12 324 1.7× 253 1.7× 51 1.0× 18 0.4× 45 1.2× 17 538
Eric Wellner Sweden 12 263 1.4× 567 3.8× 56 1.1× 28 0.6× 21 0.6× 17 805
Felicia Ying-Hsiueh Wu United States 15 435 2.3× 100 0.7× 57 1.1× 82 1.9× 28 0.8× 19 663
Donald D. Giannini United States 14 130 0.7× 194 1.3× 42 0.8× 79 1.8× 8 0.2× 25 504

Countries citing papers authored by A. Hempel

Since Specialization
Citations

This map shows the geographic impact of A. Hempel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Hempel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Hempel more than expected).

Fields of papers citing papers by A. Hempel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Hempel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Hempel. The network helps show where A. Hempel may publish in the future.

Co-authorship network of co-authors of A. Hempel

This figure shows the co-authorship network connecting the top 25 collaborators of A. Hempel. A scholar is included among the top collaborators of A. Hempel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Hempel. A. Hempel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Camerman, A., A. Hempel, D. Mastropaolo, & N. Camerman. (2005). 2-Acetamido-N-benzyl-2-(methoxyamino)acetamides: functionalized amino acid anticonvulsants. Acta Crystallographica Section C Crystal Structure Communications. 61(7). o417–o419. 3 indexed citations
2.
Hempel, A., N. Camerman, Zbigniew Dauter, D. Mastropaolo, & A. Camerman. (2000). The antiestrogen [2-(4-benzylphenoxy)ethyl]diethylammonium chloride. Acta Crystallographica Section C Crystal Structure Communications. 56(4). 455–456.
3.
Hempel, A., N. Camerman, D. Mastropaolo, & A. Camerman. (2000). Ranitidine hydrochloride, a polymorphic crystal form. Acta Crystallographica Section C Crystal Structure Communications. 56(8). 1048–1049. 21 indexed citations
4.
Hempel, A., N. Camerman, D. Mastropaolo, & A. Camerman. (2000). The antifolate trimetrexate: observation of the enzyme-binding conformation. Acta Crystallographica Section C Crystal Structure Communications. 56(10). 1225–1227. 3 indexed citations
5.
Camerman, A., D. Mastropaolo, A. Hempel, & N. Camerman. (2000). Hydrogen bonding interaction of diphenylbarbituric acid and 9-ethyladenine. Crystal structure of a 1:1 complex. Canadian Journal of Chemistry. 78(8). 1045–1051. 1 indexed citations
6.
Hempel, A., N. Camerman, D. Mastropaolo, & A. Camerman. (1999). Bis(2,2-dimethylaziridinyl)phosphinic amide. Acta Crystallographica Section C Crystal Structure Communications. 55(7). 1173–1175. 4 indexed citations
7.
Hempel, A., N. Camerman, John R. Grierson, D. Mastropaolo, & A. Camerman. (1999). FF-β-D-Arabinofuranosyluracil. Acta Crystallographica Section C Crystal Structure Communications. 55(4). 632–633. 2 indexed citations
8.
Wu, Tai-Wing, Ling-Hua Zeng, Jun Wu, et al.. (1996). Molecular structure and antioxidant specificity of purpurogallin in three types of human cardiovascular cells. Biochemical Pharmacology. 52(7). 1073–1080. 32 indexed citations
9.
Hempel, A., N. Camerman, John R. Grierson, D. Mastropaolo, & A. Camerman. (1996). Stereochemistry of Chiral Sulfoxides used for the Synthesis of Antitumor Antibiotic Analogues of Sparsomycin. Acta Crystallographica Section C Crystal Structure Communications. 52(12). 3207–3210.
10.
Wood, D. D., Henrianna Pang, A. Hempel, et al.. (1995). Participation of Acetylpseudouridine in the Synthesis of a Peptide Bond in Vitro. Journal of Biological Chemistry. 270(36). 21040–21044. 101 indexed citations
11.
Wu, Tai-Wing, Kwok‐Pui Fung, Jun Wu, et al.. (1995). Molecular properties and myocardial salvage effects of morin hydrate. Biochemical Pharmacology. 49(4). 537–543. 46 indexed citations
12.
Hempel, A., N. Camerman, D. Mastropaolo, & A. Camerman. (1993). Glucosidase inhibitors: structures of deoxynojirimycin and castanospermine. Journal of Medicinal Chemistry. 36(25). 4082–4086. 32 indexed citations
13.
Perrakis, Anastassis, et al.. (1993). Molecular and crystal structure of 2-amino-6-dimethylamino-4-(tricyclo[3.3.1.13, 7]dec-1-yl) methyl-1,3,5-triazine. Journal of Chemical Crystallography. 23(10). 821–824. 1 indexed citations
14.
Antoniadou‐Vyza, Ekaterini, Elias Eliopoulos, Anna Tsantili‐Kakoulidou, et al.. (1993). Synthesis, crystal structure and biological properties of a new series of lipophilic s-triazines, dihydrofolate reductase inhibitors. European Journal of Medicinal Chemistry. 28(2). 149–158. 19 indexed citations
15.
Hamodrakas, Stavros J., et al.. (1992). Molecular and crystal structure of 2-amino-4-(tricyclo[3.3.1.1.3,7]decyl-1)-6-N-methyl-piperazino-1,3,5-triazine. Journal of Chemical Crystallography. 22(5). 607–614. 2 indexed citations
17.
Hempel, A., N. Camerman, & A. Camerman. (1989). Crystallographic resolution and crystal and molecular structures of stereoisomers of 1,3,5-triglycidyl-s-triazinetrione. Journal of Medicinal Chemistry. 32(3). 648–651. 4 indexed citations
18.
Hempel, A., N. Camerman, & A. Camerman. (1983). Stereochemistry of conformationally restricted analogs of the antitumor agent ICRF-159. 2. Structures of antimetastatically active and inactive isomers of a tricyclic analog. Journal of the American Chemical Society. 105(8). 2350–2354. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026